Edwards Lifesciences Corp. (EW)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 2 |
Ownership rank: | 356 |
% of all portfolios: | 0.082% |
Hold Price * : | $72.74 |
History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
Q2  2024 | |||||
≡ | David Rolfe - Wedgewood Partners | Add 44.40% | 108,976 | 1.46 | |
≡ | Francois Rochon - Giverny Capital | Add 0.07% | 298 | 0.00 | |
Q1  2024 | |||||
≡ | Francois Rochon - Giverny Capital | Add 1.09% | 4,812 | 0.02 | |
Q4  2023 | |||||
≡ | David Rolfe - Wedgewood Partners | Add 29.34% | 56,855 | 1.03 | |
≡ | Francois Rochon - Giverny Capital | Add 0.07% | 304 | 0.00 | |
Q3  2023 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 22.93% | 990 | 0.00 | |
≡ | Francois Rochon - Giverny Capital | Add 0.16% | 706 | 0.00 | |
Q2  2023 | |||||
≡ | Francois Rochon - Giverny Capital | Add 6.01% | 24,921 | 0.12 | |
Q1  2023 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 96.94% | 3,511 | 0.01 | |
Q4  2022 | |||||
≡ | David Rolfe - Wedgewood Partners | Add 0.64% | 2,133 | 0.03 | |
Q3  2022 | |||||
≡ | Francois Rochon - Giverny Capital | Add 3.19% | 13,314 | 0.07 | |
≡ | Lee Ainslie - Maverick Capital | Buy | 14,238 | 0.03 | |
≡ | Terry Smith - Fundsmith | Buy | 9,979 | 0.00 | |
Q2  2022 | |||||
≡ | Francois Rochon - Giverny Capital | Add 2.91% | 11,791 | 0.07 | |
Q1  2022 | |||||
≡ | David Rolfe - Wedgewood Partners | Add 1.44% | 5,071 | 0.08 | |
Q4  2021 | |||||
≡ | Francois Rochon - Giverny Capital | Add 0.90% | 3,612 | 0.02 | |
Q2  2021 | |||||
≡ | Francois Rochon - Giverny Capital | Add 3.94% | 15,389 | 0.10 | |
Q1  2021 | |||||
≡ | Francois Rochon - Giverny Capital | Add 0.60% | 2,326 | 0.01 | |
Q4  2020 | |||||
≡ | Francois Rochon - Giverny Capital | Add 3.85% | 14,392 | 0.10 | |
Q3  2020 | |||||
≡ | Francois Rochon - Giverny Capital | Add 0.21% | 795 | 0.01 | |
Q2  2020 | |||||
≡ | Francois Rochon - Giverny Capital | Add 214.65% | 254,201 | 1.75 | |
≡ | David Rolfe - Wedgewood Partners | Add 181.85% | 431,342 | 5.05 | |
≡ | Lee Ainslie - Maverick Capital | Buy | 30,541 | 0.04 | |
Q4  2019 | |||||
≡ | AKO Capital | Add 28.74% | 184,924 | 0.93 | |
≡ | Francois Rochon - Giverny Capital | Add 1.01% | 1,282 | 0.03 | |
Q3  2019 | |||||
≡ | AKO Capital | Add 12.84% | 73,245 | 0.39 | |
≡ | Francois Rochon - Giverny Capital | Add 0.19% | 243 | 0.01 | |
≡ | Viking Global Investors | Buy | 204,148 | 0.23 | |
Q2  2019 | |||||
≡ | AKO Capital | Add 24.41% | 111,903 | 0.53 | |
≡ | Francois Rochon - Giverny Capital | Add 2.47% | 3,067 | 0.06 | |
Q1  2019 | |||||
≡ | Francois Rochon - Giverny Capital | Add 1.43% | 1,745 | 0.04 | |
Q4  2018 | |||||
≡ | David Rolfe - Wedgewood Partners | Add 0.27% | 2,172 | 0.02 | |
Q3  2018 | |||||
≡ | Francois Rochon - Giverny Capital | Add 4.74% | 8,182 | 0.16 | |
Q2  2018 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 36.13% | 27,030 | 0.05 | |
≡ | Francois Rochon - Giverny Capital | Add 0.78% | 1,342 | 0.03 | |
Q1  2018 | |||||
≡ | Francois Rochon - Giverny Capital | Add 5.94% | 9,595 | 0.18 | |
Q4  2017 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 73.15% | 33,570 | 0.05 | |
Q3  2017 | |||||
≡ | David Rolfe - Wedgewood Partners | Add 55.92% | 481,699 | 1.80 | |
≡ | Lee Ainslie - Maverick Capital | Add 36.25% | 12,210 | 0.02 | |
Q2  2017 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 9.03% | 2,790 | 0.00 | |
Q1  2017 | |||||
≡ | David Rolfe - Wedgewood Partners | Buy | 1,137,072 | 2.75 | |
Q4  2016 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 42.90% | 11,540 | 0.02 | |
Q2  2016 | |||||
≡ | Lee Ainslie - Maverick Capital | Buy | 32,300 | 0.04 | |
Q1  2015 | |||||
≡ | Lee Ainslie - Maverick Capital | Buy | 3,920 | 0.00 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.